The US FDA is faced with lapsed funding appropriations as the US government shutdown continues, causing the agency to focus on addressing immediate threats to consumer safety.
Upperton’s new R&D facility receives MHRA approval
from Outsourcing-Pharma.com
Sun Pharma recalls 140,000 vials contaminated with glass particles
from in-PharmaTechnologist.com
US FDA on-board with first inhaled treatment for Parkinson’s
from in-PharmaTechnologist.com
Iqvia's new safety platform looks to reduce pharmacovigilance costs, complexity
from Outsourcing-Pharma.com
DuPont excipient could ‘double to triple’ biologics’ shelf life
Pipelines
‘An incredible opportunity’: Takeda signs immuno-oncology collaborations
Cell & Gene Therapies
BMS-Celgene deal: CEO looking to the ‘evolution’ of market with cell therapies
Pipelines
From CAR-T to CAAR-T: Funding drives biotech into emerging space
Cell & Gene Therapies
